Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | HTR1B | P28222 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4711267 | 1.00 | CYP1A2 (0.41) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| Hydrochloric Acid SCHEMBL4713745 | 0.99 | CYP1A2 (0.40) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| Hydrochloric Acid SCHEMBL4713742 | 0.99 | CYP1A2 (0.40) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| SCHEMBL4713483 | 0.90 | KDM4E (0.43) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| SCHEMBL4713484 | 0.90 | KDM4E (0.43) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| SCHEMBL4713204 | 0.89 | HRH3 (0.44) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| SCHEMBL4713201 | 0.89 | HRH3 (0.44) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| Hydrochloric Acid SCHEMBL4711116 | 0.88 | HRH3 (0.43) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| Hydrochloric Acid SCHEMBL4711111 | 0.88 | HRH3 (0.43) | CYP1A2CYP2D6CYP2C19S1PR4HRH3 | |
| SCHEMBL4711192 | 0.88 | CYP1A2 (0.46) | CYP1A2CYP2D6CYP2C19MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0998459-B1 | PYRIDINE DERIVATIVES | NOVARTIS AG (CH) | 2008-04-23 | — | — | EP | claimed |
| EP-0998459-A2 | PYRIDINE DERIVATIVES | Novartis AG (CH) | 2000-05-10 | — | — | EP | claimed |
| WO-1999002497-A2 | PYRIDINE DERIVATIVES | NOVARTIS AG (CH) | 1999-01-21 | — | — | WO | claimed |
| EP-0998459-B1 | PYRIDINE DERIVATIVES | NOVARTIS AG (CH) | 2008-04-23 | — | — | EP | disclosed |
| EP-1117403-B1 | MGLUR5 ANTAGONISTS FOR THE TREATMENT OF PAIN AND ANXIETY | NOVARTIS AG (CH) | 2003-12-10 | — | — | EP | disclosed |
| US-6656957-B1 | Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. | NOVARTIS AG (CH) | 2003-12-02 | — | — | US | disclosed |
| EP-0998459-A2 | PYRIDINE DERIVATIVES | Novartis AG (CH) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999002497-A2 | PYRIDINE DERIVATIVES | NOVARTIS AG (CH) | 1999-01-21 | — | — | WO | disclosed |